« FDA and ONC Work Together to Spur Innovation in Mobile Health Technologies | Main | Affordable Care Act Survey: 31% of Uninsured Americans Have Not Heard of Healthcare Exchanges, Feel Unprepared As ACA Deadline Approaches »

December 11, 2013

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e5520572bb8834019b028dd7c8970c

Listed below are links to weblogs that reference ProPublica Criticizes Prescribing Brand-Name Drugs with Little Consideration to the Benefit:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

Sponsors

Enter your Email:
Preview | Powered by FeedBlitz

December 2014

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31